RAP 0.00% 20.5¢ resapp health limited

Ann: ResApp expands COVID-19 clinical program, page-22

  1. 26,687 Posts.
    lightbulb Created with Sketch. 1732
    You do know it wasn't consider price sensitive because RAP already announced to the market they were doing clinical trial to screen for COVID-19.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.